FDA Approves Risankizumab, Adds Stronger Warning to Sleep Medications
British Columbia Will Be First Canadian Province to Switch Patients to Biosimilars
Ixekizumab Promising for Non-Radiographic Axial SpA; Plus FDA Approves Belimumab for Pediatric Lupus
Common Characteristics in RA Patients Who Don’t Respond to Biologics
IV Meloxicam Stalls at FDA; Plus Health Canada Approves Risankizumab for Plaque Psoriasis
Health Canada Approves Certolizumab Pegol & NICE Issues Guidance for Certolizumab Pegol
Osteoporotic Fracture Rates Similar with Denosumab, Alendronate in Real World
IBD Patients Who Switch from Infliximab to Biosimilar See Mixed Results
Japan Approves Risankizumab for Psoriasis & Psoriatic Arthritis
- « Previous Page
- 1
- 2
- 3
- 4
- 5
- …
- 32
- Next Page »